Trial Profile

A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 (a Fibrin Derived Peptide Bbeta15-42) on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The `F.I.R.E.' Study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Nov 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Nov 2012 Planned number of patients changed from 140 to 220 as reported by European Clinical Trials Database record.
31 Mar 2009 Results of a prespecified subgroup analysis investigating effects of time to therapy were presented at the American College of Cardiology (ACC-2009).
24 Feb 2009 Results are published in Journal of the American College of Cardiology 53: 720-729, No. 8, 24 Feb 2009.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com